Per Olsson Gisleskog

6PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus.

|May 29, 2026
Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials.

|Jul 04, 2025
Population Pharmacokinetic and Exposure-Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma.

Per Olsson Gisleskog, Belén Valenzuela, Nicoline Treijtel

|Jan 27, 2025
Evaluation of the Effect of Loperamide on the Cardiac Repolarization Interval Using Exposure-Response Analysis.

Belén Valenzuela, Per Olsson Gisleskog, Iolanda Cirillo

|Apr 29, 2021
An Exposure-Response Analysis of the Clinical Efficacy of Ponesimod in a Randomized Phase II Study in Patients with Multiple Sclerosis.

Per Olsson Gisleskog, Belén Valenzuela, Tatiana Scherz

|Dec 23, 2020
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.

Per O Olsson Gisleskog, Juan José Perez Ruixo, Åke Westin

Pageof 1

Frequent Collaborators

5 joint publications

Juan Jose Pérez-Ruixo

3 joint publications

Belén Valenzuela

2 joint publications

Oliver Ackaert

1 joint publications

Åke Westin